Idexx Laboratories (IDXX) Total Debt (2009 - 2026)

Idexx Laboratories' Total Debt history runs 18 years deep, the most recent figure standing at $449.9 million for Q1 2026.

• In Q1 2026, Total Debt fell 41.52% year-over-year to $449.9 million; the TTM figure through Mar 2026 stood at $449.9 million (down 41.52% YoY), while the FY2025 annual figure was $772.8 million, up 25.14% from the prior year.
• Total Debt for Q1 2026 stood at $449.9 million, down from $772.8 million in the prior quarter.
• The five-year high for Total Debt was $1.4 billion in Q3 2022, with the low at $449.9 million in Q1 2026.
• The 5-year median for Total Debt is $870.8 million (2024), against an average of $882.9 million.
• The sharpest annual moves came in 2022 and 2023: Total Debt soared 63.4% in 2022, then sank 44.84% in 2023.
• Idexx Laboratories' Total Debt stood at $944.4 million in 2022, then dropped by 7.57% to $872.9 million in 2023, then declined by 29.25% to $617.6 million in 2024, then climbed by 25.14% to $772.8 million in 2025, then tumbled by 41.79% to $449.9 million in 2026.
• Business Quant data shows IDXX's Total Debt at $449.9 million in Q1 2026, $772.8 million in Q4 2025, and $524.8 million in Q3 2025.